Over the past 70 years, The Leukemia & Lymphoma Society (LLS) has invested nearly $1.3 billion in blood cancer research, making it a global leader in the fight against cancer. The key mission priorities of LLS are focused on research, patient education and support, and advocacy.
In this article, explore the following four sections to learn about one of LLS' key fundraising campaigns, meet former fundraising volunteers, browse a list of this year's candidates [Melissa D. Zier] and discover a new initiative to accelerate new and better treatments for pediatric blood cancers.